ACAD FY 2010 Earnings — ACADIA Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

ACADACADIA Pharmaceuticals Inc.

$4B

FY 2010 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$42M+558.5% YoY

Gross Profit

$42M100.0% margin

Operating Income

$15M35.8% margin

Net Income

$15M35.9% margin

EPS (Diluted)

$0.39

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$38M

Total Liabilities

$9M

Stockholders' Equity

$30M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$42M	$6M	+558.5%
Gross Profit	$42M	$6M	+558.5%
Operating Income	$15M	-$45M	+133.2%
Net Income	$15M	-$45M	+133.5%